PNC Financial Services Group Inc. raised its holdings in Illumina, Inc. (NASDAQ:ILMN) by 6.9% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 55,791 shares of the life sciences company’s stock after acquiring an additional 3,577 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Illumina were worth $9,681,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of ILMN. HPM Partners LLC lifted its stake in Illumina by 29,103.8% in the second quarter. HPM Partners LLC now owns 751,999 shares of the life sciences company’s stock valued at $107,724,000 after acquiring an additional 749,424 shares during the last quarter. TIAA CREF Investment Management LLC lifted its stake in shares of Illumina by 55.6% in the second quarter. TIAA CREF Investment Management LLC now owns 1,475,669 shares of the life sciences company’s stock worth $256,058,000 after buying an additional 527,548 shares during the last quarter. American Century Companies Inc. lifted its stake in shares of Illumina by 276.9% in the second quarter. American Century Companies Inc. now owns 475,111 shares of the life sciences company’s stock worth $82,441,000 after buying an additional 349,058 shares during the last quarter. Vanguard Group Inc. lifted its stake in shares of Illumina by 3.0% in the first quarter. Vanguard Group Inc. now owns 9,648,842 shares of the life sciences company’s stock worth $1,646,479,000 after buying an additional 285,379 shares during the last quarter. Finally, SG Americas Securities LLC lifted its stake in shares of Illumina by 517.3% in the second quarter. SG Americas Securities LLC now owns 276,301 shares of the life sciences company’s stock worth $47,944,000 after buying an additional 231,539 shares during the last quarter. Hedge funds and other institutional investors own 93.32% of the company’s stock.

Illumina, Inc. (NASDAQ ILMN) opened at 201.41 on Friday. The firm has a market cap of $29.41 billion, a P/E ratio of 40.41 and a beta of 0.81. The company’s 50-day moving average is $199.76 and its 200 day moving average is $181.17. Illumina, Inc. has a 12 month low of $119.37 and a 12 month high of $214.34.

Illumina (NASDAQ:ILMN) last released its earnings results on Tuesday, August 1st. The life sciences company reported $0.82 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.68 by $0.14. Illumina had a return on equity of 19.69% and a net margin of 30.27%. The firm had revenue of $662.00 million for the quarter, compared to analysts’ expectations of $642.38 million. During the same quarter in the previous year, the business posted $0.86 earnings per share. The business’s revenue for the quarter was up 10.3% on a year-over-year basis. Equities research analysts expect that Illumina, Inc. will post $3.65 EPS for the current fiscal year.

A number of brokerages have recently weighed in on ILMN. First Analysis upgraded shares of Illumina from an “underweight” rating to an “equal weight” rating and set a $176.00 price objective for the company in a research note on Wednesday, August 2nd. Zacks Investment Research cut shares of Illumina from a “buy” rating to a “hold” rating in a research note on Friday, August 4th. Barclays PLC restated an “equal weight” rating and issued a $150.00 price objective on shares of Illumina in a research note on Wednesday, August 9th. Canaccord Genuity restated a “hold” rating and issued a $170.00 price objective on shares of Illumina in a research note on Wednesday, July 26th. Finally, BidaskClub cut shares of Illumina from a “hold” rating to a “sell” rating in a research note on Thursday, August 17th. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and eleven have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $182.15.

COPYRIGHT VIOLATION NOTICE: “PNC Financial Services Group Inc. Has $9.68 Million Holdings in Illumina, Inc. (ILMN)” was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this news story can be viewed at https://www.thecerbatgem.com/2017/09/23/pnc-financial-services-group-inc-has-9-68-million-holdings-in-illumina-inc-ilmn.html.

In other Illumina news, Director Jay T. Flatley sold 20,000 shares of Illumina stock in a transaction dated Tuesday, September 12th. The stock was sold at an average price of $211.11, for a total value of $4,222,200.00. Following the transaction, the director now owns 539,176 shares in the company, valued at $113,825,445.36. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Oene Mark Van sold 9,729 shares of Illumina stock in a transaction dated Tuesday, September 12th. The shares were sold at an average price of $211.33, for a total value of $2,056,029.57. Following the completion of the transaction, the senior vice president now owns 24,908 shares in the company, valued at approximately $5,263,807.64. The disclosure for this sale can be found here. In the last quarter, insiders sold 175,188 shares of company stock worth $33,870,937. Company insiders own 1.60% of the company’s stock.

Illumina Profile

Illumina, Inc (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations.

Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)

Receive News & Stock Ratings for Illumina Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina Inc. and related stocks with our FREE daily email newsletter.